- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Novel no stain digital histopathology by hybrid microscope
CHAMPAIGN, Ill. -- The ability to provide label-free molecular information of ubiquitous optical microscope can be enhanced by infrared (IR) spectroscopy. Researchers at the University of Illinois at Urbana-Champaign hope to bring cancer diagnosis into the digital era by adding the infrared capability to the ubiquitous, standard optical microscope.
Optical microscopy for biomedical samples requires expertise in staining to visualize structure and composition. Pairing infrared measurements with high-resolution optical images and machine learning algorithms, the researchers created digital biopsies that closely correlated with traditional pathology techniques and also outperformed state-of-the-art infrared microscopes. Led by Rohit Bhargava, a professor of bioengineering and the director of the Cancer Center at Illinois, the group published its results in the Proceedings of the National Academy of Sciences.
"The advantage is that no stains are required, and both the organization of cells and their chemistry can be measured. Measuring the chemistry of tumour cells and their microenvironment can lead to better cancer diagnoses and a better understanding of the disease," Bhargava said.
The gold standard of tissue pathology is to add dyes or stains so that pathologists can see the shapes and patterns of the cells under a microscope. However, it can be difficult to distinguish cancer from healthy tissue or to pinpoint the boundaries of a tumour, and in many cases diagnosis is subjective.
"For more than a century, we have relied on adding dyes to human tissue biopsies to diagnose tumours. However, the shape and colour induced by the dye provide very limited information about the underlying molecular changes that drive cancer," Bhargava said.
Technologies like infrared microscopy can measure the molecular composition of tissue, providing quantitative measures that can distinguish cell types. Unfortunately, infrared microscopes are expensive and the samples require special preparation and handling, making them impractical for the vast majority of clinical and research settings.
Bhargava's group developed its hybrid microscope by adding an infrared laser and a specialized microscope lens, called an interference objective, to an optical camera. The infrared-optical hybrid measures both infrared data and a high-resolution optical image with a light microscope - the kind ubiquitous in clinics and labs.
"We built the hybrid microscope from off-the-shelf components. This is important because it allows others to easily build their own microscope or upgrade an existing microscope," said Martin Schnell, a postdoctoral fellow in Bhargava's group and first author of the paper.
Combining the two techniques harnesses the strengths of both, the researchers said. It has the high resolution, large field-of-view and accessibility of an optical microscope. Furthermore, infrared data can be analyzed computationally, without adding any dyes or stains that can damage tissues. Software can recreate different stains or even overlap them to create a more complete, all-digital picture of what's in the tissue.
The researchers verified their microscope by imaging breast tissue samples, both healthy and cancerous, and comparing the results of the hybrid microscope's computed "dyes" with those from the traditional staining technique. The digital biopsy closely correlated with the traditional one.
Furthermore, the researchers found that their infrared-optical hybrid outperformed state-of-the-art in infrared microscopes in several ways: It has 10 times larger coverage, greater consistency and four times higher resolution, allowing infrared imaging of larger samples, in less time, with unprecedented detail.
"Infrared-optical hybrid microscopy is widely compatible with conventional microscopy in biomedical applications," Schnell said. "We combine the ease of use and universal availability of optical microscopy with the wide palette of infrared molecular contrast and machine learning. And by doing so, we hope to change how we routinely handle, image and understand microscopic tissue structure."
The researchers plan to continue refining the computational tools used to analyze the hybrid images. They are working to optimize machine-learning programs that can measure multiple infrared wavelengths, creating images that readily distinguish between multiple cell types, and integrate that data with the detailed optical images to precisely map cancer within a sample. They also plan to explore further applications for hybrid microscope imaging, such as forensics, polymer science and other biomedical applications.
"It is very intriguing what this additional detail can offer in terms of pathology diagnoses," Bhargava said. "This could help speed up the wait for results, reduce costs of reagents and people to stain tissue, and provide an 'all-digital' solution for cancer pathology."
for further references log on to:
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751